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Idiosyncratic reactions to drugs are 
adverse effects not straightly related with 
pharmacodynamic mechanisms of the 
drug and they can take place on unpre-
dictable way by abnormal interaction be-
tween the drug and the organism, usually 
mediated by immunologic or cytotoxic ef-
fects triggered by the drug or its metabo-
lites1. Even being responsible for 6-10 % of 
all the adverse reactions to drugs, the idio-
syncratic effects can be important sources 
of morbidity and mortality, mainly in chil-
dren1. The anti-epileptic drugs (AED) also 
can cause adverse effects by these mech-
anisms, which impairs the seizure control 
and obliges the physician to use second 
line drugs. A study in epileptic patients 
showed that 10 to 27 % stopped their first 
treatment with AED on account of the ad-
verse effects, being several of them idio-
syncratic1. Valproic acid (VPA) is a car-
boxylic acid used as anti-epileptic in id-
iopathic and symptomatic generalized ep-
ilepsies and in some cases of symptomat-
ic focal epilepsies, as well as for trigeminal 
neuralgia, migraine and bipolar disorders3. 
Its mechanism is unknown, however it is 
probably associated with the metabolism 
of the neurotransmitter GABA. The toxic 
effects it provokes can be dose-dependent 
or idiosyncratic. There are several VPA-re-
lated idiosyncrasies, being the most note-
worthy alopecia, bone marrow aplasia, im-
mune-mediated hepatotoxicity and pan-
creatitis1. The acute pancreatitis is a disease 
of several etiologies, sometimes caused by 
use of determined drugs. The pancreatitis 
provoked by VPA is a rare entity, with es-
timated incidence of 1:400002, occurring 
mainly during the first year of treatment 
or after increase in the dose, with high-
er incidence in young individuals, in poly-
therapy (mainly with carbamazepine, phe-
nytoin, phenobarbital and some benzodi-
azepines), with chronic encephalopathies 
and in dialysis treatment1,2. The supposed 
pathogenic mechanism is by direct toxic 
effect of free radicals in the membranes of 
the pancreatic cells2,3,5,6. The onset can be a 
slight asymptomatic hyperamylasemia up 
to a fatal necrohemorragic pancreatitis4, 
and the mortality varies from 17 to 20%, 
with many complications in the non-le-
thal cases (pseudocysts, infections, sep-
tic shock, chronic pancreatitis, endocrine 
pancreatic insufficiency)2. The treatment is 
based on the immediate withdrawal of the 
drug, general clinical support and specif-
ic treatment of the possible complications.
We present the case of a patient who, 
in less than 2 months of treatment with 
appropriate dose of VPA, evolved to pan-
creatitis.
CASE
A male 34 years-old, white, resident 
at Ribeirão Preto, tattooist, single, with 
a past history of depressive episode, be-
gan to have complex partial seizures by 
25 years of age, in increasing frequency. 
After the diagnosis of focal epilepsy, he 
was put on VPA, in dose of 16.5 mg/kg/
day, increasing up to 25 mg/kg/day after 
25 days as the initial dose. After such in-
crease in daily dose, he felt a mild epigas-
tric pain, improved by symptomatic med-
icines, however on a progressive pattern. 
After 15 days using VPA at 25 mg/kg/day, 
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there was worsening of epigastric pain with became very 
intense, enhancing after food, irradiating to the dorsal 
area of trunk, associated with vomiting and anorexia. He 
was admitted in an emergency room, with serum amy-
lase of 1682 UI/L, being transferred to our service under 
the suspicion of acute pancreatitis. There was no history 
of ethylic abusive drinking, abdominal traumas nor recent 
infectious disorders. On physical examination, he was afe-
brile, normal vital signs and diffuse abdominal pain, with-
out signs of peritonitis. Laboratorial workup showed leu-
kocytosis, serum amylase of 1743 UI/L, lipase 375 UI/L, 
normal arterial blood gas analysis, without scoring in the 
Ranson’s severity criteria in the admission and APACHE 
II of 4 points. Clinical measures for acute pancreatitis 
were provided; he was put off VPA and started on car-
bamazepine. On abdominal ultrasound, showed no alter-
ation in the biliary tract, with some increase in pancreat-
ic volume and small ascitis. Abdominal CT scan showed 
a diffuse increase in pancreas volume, presence of per 
pancreatic liquid, slight ascitis and a small pleural effu-
sion on the left, classified as edematous acute pancreatitis 
Balthazar B. The lipid profile was normal, with low serum 
VPA level and normal plasma ammonia. HIV and hep-
atitis serologic tests were negative. The patient went on 
well, without recurrence of the abdominal pain with fast-
ing, with no scoring in Ranson’s criteria after 48 hours. 
Oral diet was gradually reintroduced with good accep-
tance and no worsening of the symptoms. He was dis-
charged in the 6th day of hospitalization, with serum am-
ylase of 341UI/L.
DISCUSSION
The first cases of acute pancreatitis associated to VPA 
were reported in 1979, by Bataladen et al.7 and Camfield 
et al.8, with several sporadic cases being published subse-
quently. There are 2 cases described in the Latin Ameri-
ca, all in Brazil, the first one in 1986, by Tannhauser Bar-
ros et al.7, and the other in 1998 by Munhoz et al.8. Most 
of the reported cases happened in children2, correspond-
ing to 13% of all cases of acute pancreatitis of childhood. 
From the first description, some literature reviews have 
been done2,4,9,10, with 106 cases described until the mo-
ment of the finishing of this report, however there are 
doubts about these numbers10.
In our case, the age of the patient is compatible with 
the most affected age group in adults, but the patient was 
not using polytherapy and the disease developed in only 
40 days after the beginning of the drug (as seen by Biour 
et al.9, there is a case with 1 day of use of VPA), in the 
appropriate dose (25 mg/kg/day), with ascending serum 
level (18,52 mg/dL), the lowest level of all reported in the 
literature, reinforcing the idiosyncratic nature of this ad-
verse reaction1. It is expected that this complication relat-
ed to a widely used drug might have an incidence much 
higher than reported in the literature, because of under 
notification, and physicians who prescribe AED on a daily 
basis, and should be aware in order to recognize the first 
signs of this disorder.
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